UBC’s Global Market Access Communications
team combines high quality technical
writing with a detailed understanding of
the needs of payer decision
makers. Experience covering nearly 150
Value Dossiers underpins a sector-leading
model for these crucial market access
deliverables. Key offerings from the group
include:
- Value Dossiers to assist companies in their pricing, reimbursement, funding and formulary listing negotiations
- Slide decks, payer objection handlers, formulary materials and handover meetings to further support market access
- Value story development, refinement and validation as a stand-alone activity or as part of Value Dossier development
- Local, country level materials to support market access including AMCP dossiers in the US
- Wider disease area literature reviews, and commercial or health technology assessment analyses.
